Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Changes in Gut Microbiota, Inflammatory Factors, and Bowel Habits Following Oral Administration of Recombinant B-subunit/Whole Cell Cholera Vaccine in a Community Population

NCT07873346 is registered in ClinicalTrials.gov with Zhejiang Provincial Center for Disease Control and Prevention as lead sponsor.

NCT NCT07873346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07873346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Changes in Gut Microbiota, Inflammatory Factors, and Bowel Habits Following Oral Administration of Recombinant B-subunit/Whole Cell Cholera Vaccine in a Community Population
Lead sponsor
Zhejiang Provincial Center for Disease Control and Prevention
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 20, 2026
Completion date
December 30, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bowel habits, gut microbiomes, inflamatory markers